key: cord-0744833-du815f72
authors: Grivas, P.; Warner, J.; Shyr, Y.; Shah, D.; Rubinstein, S. M.; Kuderer, N. M.; Choueiri, T. K.; Rivera, D.; Painter, C.; Thompson, M. A.; Peters, S.; Desai, A.; Khaki, A. R.; Pennell, N. A.; Hawley, J.; Halmos, B.; Puc, M. M.; Lyman, G. H.; Rini, B. I.; Lopes, G.
title: Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19)
date: 2020-09-30
journal: Annals of Oncology
DOI: 10.1016/j.annonc.2020.08.2313
sha: 11976ca60f3c4c313c8e69a3f9114307363360ed
doc_id: 744833
cord_uid: du815f72

nan

Conclusions: We confirmed a priori identified risk factors for poor prognosis in the largest COVID-19/cancer cohort and performed initial analysis of lab parameters, informing risk assessment.

Clinical trial identification: NCT04354701.

Legal entity responsible for the study: The COVID-19 and Cancer Consortium (CCC19). 

LBA73 The ORF1ab of SARS-CoV-2 encodes an immunodominant epitope restricted by HLA-A*

Background: A large global effort is ongoing to develop vaccines against SARS-CoV-2, the causative agent of COVID-19. While there is accumulating information on the antibody response against SARS-CoV-2, less is known about the SARS-CoV-2 antigens that are targeted by CD8 T cells. Such knowledge will be of high value to gain fundamental insights into the antigenic landscape of SARS-CoV-2 recognized by CD8 T cells, to develop tool allowing focused analysis of the SARS-CoV-2 specific T cell responses directly ex vivo

Methods: To address this issue, we have analyzed samples from 18 COVID-19 patients for CD8 T cell recognition of 500 predicted SARS-CoV-2-derived epitopes restricted to 10 common HLA-A and HLA-B alleles. For each HLA allele, the top 50 epitopes were selected based on predicted binding affinity and likelihood of successful proteasomal processing. To probe for CD8 T cell recognition of the selected epitope-HLA complexes, we made use of our in-house technology based on multiplexing of peptide HLA

derived from the spike protein of SARS-CoV-2, we have identified several CD8 T cell recognized epitopes derived from the ORF1ab, including one epitope displaying clear immunodominant properties across patients positive for HLA-A*01:01. Investigation of the functional status of part of the identified responses